Dagondon, Julie S.

HRN: 22-89-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFUROXIME 750MG (VIAL)
07/09/2023
07/15/2023
IVT
750mg
Q8
Pleomorphic Adenoma Parotid Gland Left
07/11/2023
CEFUROXIME 1.5GM (VIAL)
07/11/2023
07/18/2023
IV
1.5g
Q8hrs
S/P Parotidectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: